Journal of Clinical Oncology, Vol 3, 1659-1667, Copyright © 1985 by American Society of Clinical Oncology

ARTICLES

Neurologic, neuropsychologic, and computed cranial tomography scan abnormalities in 2- to 10-year survivors of small-cell lung cancer

BE Johnson, B Becker, WB Goff 2d, N Petronas, MA Krehbiel, RW Makuch, G McKenna, E Glatstein and DC Ihde

In order to evaluate the relationship between neurologic function and cranial irradiation, 20 patients treated on National Cancer Institute (NCI) small-cell lung cancer (SCLC) trials who were alive and free of cancer 2.4 to 10.6 years (median, 6.2) from the start of therapy were studied. All were tested with a neurologic history and examination, mental status examination, neuropsychologic testing, and review of serial computed cranial tomography (CCT) scans. Fifteen patients had been treated with prophylactic cranial irradiation (PCI), two patients with therapeutic cranial irradiation, and three received no cranial irradiation. All patients but one were ambulatory and none were institutionalized. Fifteen patients (75%) had neurologic complaints, 13 (65%) had abnormal neurologic examinations, 12 (60%) had abnormal mental status examinations, 13 (65%) had abnormal neuropsychologic testing, and 15 (75%) had abnormal CCT scans. Compared with those given low-dose maintenance chemotherapy during PCI using 200 to 300 rad per fraction, patients who were given high-dose induction chemotherapy during the time of cranial irradiation or large radiotherapy fractions (400 rad) were more likely to have abnormal mental status examinations (6/6 v 4/9) and abnormal neuropsychologic tests (6/6 v 4/9), but no major difference in CCT findings was present. CCT scans in the majority of cases (11/18) showed progressive ventricular dilatation or cerebral atrophy up to 8 years after stopping therapy. We conclude neurologic abnormalities are common in long-term survivors of SCLC, and may be more prominent in patients given high-dose chemotherapy during cranial irradiation or treated with large radiotherapy fractions. The CCT scan abnormalities are common and progressive years after prophylactic cranial irradiation and chemotherapy are stopped.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Pottgen, W. Eberhardt, A. Grannass, S. Korfee, G. Stuben, H. Teschler, G. Stamatis, H. Wagner, B. Passlick, V. Petersen, et al. Prophylactic Cranial Irradiation in Operable Stage IIIA Non Small-Cell Lung Cancer Treated With Neoadjuvant Chemoradiotherapy: Results From a German Multicenter Randomized Trial J. Clin. Oncol., November 1, 2007; 25(31): 4987 - 4992. [Abstract] [Full Text] [PDF]

				J. J. Lee, B. N. Bekele, X. Zhou, S. B. Cantor, R. Komaki, and J. S. Lee Decision Analysis for Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer J. Clin. Oncol., August 1, 2006; 24(22): 3597 - 3603. [Abstract] [Full Text] [PDF]

				E. G. Shaw, R. Rosdhal, R. B. D'Agostino Jr, J. Lovato, M. J. Naughton, M. E. Robbins, and S. R. Rapp Phase II Study of Donepezil in Irradiated Brain Tumor Patients: Effect on Cognitive Function, Mood, and Quality of Life J. Clin. Oncol., March 20, 2006; 24(9): 1415 - 1420. [Abstract] [Full Text] [PDF]

				D. Farray, N. Mirkovic, and K. S. Albain Multimodality Therapy for Stage III Non-Small-Cell Lung Cancer J. Clin. Oncol., May 10, 2005; 23(14): 3257 - 3269. [Abstract] [Full Text] [PDF]

				H. Kattlove and R. J. Winn Ongoing Care of Patients After Primary Treatment for Their Cancer CA Cancer J Clin, May 1, 2003; 53(3): 172 - 196. [Abstract] [Full Text] [PDF]

				P. Sostak, C.S. Padovan, T.A. Yousry, G. Ledderose, H.-J. Kolb, and A. Straube Prospective evaluation of neurological complications after allogeneic bone marrow transplantation Neurology, March 11, 2003; 60(5): 842 - 848. [Abstract] [Full Text] [PDF]

				L. C. W. Lam, S. F. Leung, and Y. L. Chan Progress of Memory Function After Radiation Therapy in Patients With Nasopharyngeal Carcinoma J Neuropsychiatry Clin Neurosci, February 1, 2003; 15(1): 90 - 97. [Abstract] [Full Text] [PDF]

				C. L. Armstrong, J. V. Hunter, G. E. Ledakis, B. Cohen, E. M. Tallent, B. H. Goldstein, Z. Tochner, R. Lustig, K. D. Judy, A. Pruitt, et al. Late cognitive and radiographic changes related to radiotherapy: Initial prospective findings Neurology, July 9, 2002; 59(1): 40 - 48. [Abstract] [Full Text] [PDF]

				S. H. Okuno and J. R. Jett Small Cell Lung Cancer: Current Therapy and Promising New Regimens Oncologist, June 1, 2002; 7(3): 234 - 238. [Abstract] [Full Text] [PDF]

				R. Arriagada, T. Le Chevalier, A. Riviere, P. Chomy, I. Monnet, E. Bardet, J. A Santos-Miranda, C. Le Pechoux, M. Tarayre, S. Benhamou, et al. Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients Ann. Onc., May 1, 2002; 13(5): 748 - 754. [Abstract] [Full Text] [PDF]

				G. Y. Yang and R. H. Matthews Prophylactic Cranial Irradiation in Small-Cell Lung Cancer Oncologist, August 1, 2000; 5(4): 293 - 298. [Abstract] [Full Text]

				D. H. Johnson Management of Small Cell Lung Cancer* : Current State of the Art Chest, December 1, 1999; 116(suppl_3): 525S - 530S. [Abstract] [Full Text] [PDF]

				L. J. Loescher, D. Welch-McCaffrey, S. A. Leigh, B. Hoffman, and F. L. Meyskens Jr Surviving Adult Cancers. Part 1: Physiologic Effects Ann Intern Med, September 1, 1989; 111(5): 411 - 432. [Abstract] [PDF]

				P. A. BUNN Jr., A. S. LICHTER, R. W. MAKUCH, M. H. COHEN, S. R. VEACH, M. J. MATTHEWS, A. J. ANDERSON, M. EDISON, E. GLATSTEIN, J. D. MINNA, et al. Chemotherapy Alone or Chemotherapy with Chest Radiation Therapy in Limited Stage Small Cell Lung Cancer: A Prospective, Randomized Trial Ann Intern Med, May 1, 1987; 106(5): 655 - 662. [Abstract] [PDF]

				E. Feldmann and J. B. Posner Episodic Neurologic Dysfunction in Patients With Hodgkin's Disease Arch Neurol, December 1, 1986; 43(12): 1227 - 1233. [Abstract] [PDF]